LMRI
Lumexa Imaging·NASDAQ
--
--(--)
--
--(--)
LMRI fundamentals
During 9M 2025, Lumexa Imaging (LMRI) reported revenue of 755.35M, a YoY change of 7.78%. Net income was -18.41M, a YoY change of 73.33%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
FY,2023 | 9M,2024 | FY,2024 | 9M,2025 | TTM |
|---|
Start Date | Jan 1, 2023 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2025 | -- |
End Date | Dec 31, 2023 | Sep 30, 2024 | Dec 31, 2024 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 935.92M -- | 700.84M -- | 948.87M +1.38% | 755.35M +7.78% | 1.00B -- |
Sales and Services Revenue | 345.79M -- | 557.02M -- | 382.32M +10.56% | 592.18M +6.31% | 417.48M -- |
Other Revenue | -- -- | 143.82M -- | -- -- | 163.17M +13.45% | -- -- |
Cost of Revenue | 836.96M -- | 626.15M -- | 852.61M +1.87% | 639.90M +2.20% | 866.35M -- |
Operating Expenses | 239.74M -- | 708.74M -- | 258.06M +7.64% | 721.62M +1.82% | 270.94M -- |
Selling, General and Administrative Expenses | 174.43M -- | 82.59M -- | 186.68M +7.02% | 81.25M -1.63% | 185.33M -- |
General and Administrative Expenses | -- -- | 50.24M -- | -- -- | 53.26M +6.01% | -- -- |
Other Operating Expenses | 65.31M -- | 626.15M -- | 71.38M +9.30% | 640.38M +2.27% | 85.61M -- |
Operating Income | 106.05M -- | -7.90M -- | 124.26M +17.17% | 33.73M +527.02% | 165.88M -- |
Non-Operating Income (Loss) | -2.15M -- | -55.27M -- | -2.71M -25.95% | -40.69M +26.38% | 11.87M -- |
Income (Loss) from Affiliates | -- -- | 47.89M -- | -- -- | 49.84M +4.06% | -- -- |
Other Non-Operating Income (Loss) | -740.00K -- | 1.48M -- | -302.00K +59.19% | 0 -100.00% | -1.78M -- |
Net Interest Expense | 1.41M -- | 104.64M -- | 2.41M +70.64% | 90.52M -13.49% | -11.71M -- |
Interest Expense | 1.41M -- | 104.64M -- | 2.41M +70.64% | 90.52M -13.49% | -11.71M -- |
Pretax Income From Continuing Operations | -119.25M -- | -63.17M -- | -79.19M +33.59% | -6.96M +88.98% | -22.99M -- |
Income Tax Expense | 2.98M -- | 5.87M -- | 14.91M +400.54% | 11.45M +94.96% | 20.48M -- |
Net Income | -122.23M -- | -69.04M -- | -94.10M +23.01% | -18.41M +73.33% | -43.47M -- |
Net Income Attributable to Minority Interests | 2.27M -- | -- -- | 2.29M +0.84% | -- -- | -- -- |
Net Income Attributable to Owners of the Company | 99.95M -- | -69.04M -- | 117.67M +17.74% | -18.41M +73.33% | 168.30M -- |
Net Income Attributable to Common Stockholders | 99.95M -- | -69.04M -- | 117.67M +17.74% | -18.41M +73.33% | 168.30M -- |
Total Comprehensive Income | -122.23M -- | -69.04M -- | -94.10M +23.01% | -18.41M +73.33% | -43.47M -- |
Total Comprehensive Income Attributable to Owners of the Company | 102.22M -- | -69.04M -- | 119.96M +17.36% | -18.41M +73.33% | 170.59M -- |
Basic EPS | -0.2 -- | -0.11 -- | -0.15 +25.00% | -0.03 +72.73% | -0.07 -- |
Basic EPS from Continuing Operations | -- -- | -0.11 -- | -- -- | -0.03 +72.73% | -- -- |
Diluted EPS | -0.2 -- | -0.11 -- | -0.15 +25.00% | -0.03 +72.73% | -0.07 -- |
Diluted EPS from Continuing Operations | -- -- | -0.11 -- | -- -- | -0.03 +72.73% | -- -- |
You can ask Aime
What factors drove the changes in Lumexa Imaging's revenue and profit?What is the revenue and EPS growth rate for Lumexa Imaging year over year?What were the key takeaways from Lumexa Imaging's earnings call?What is the market's earnings forecast for Lumexa Imaging next quarter?What is Lumexa Imaging's latest dividend and current dividend yield?What is Lumexa Imaging's gross profit margin?What were the key takeaways from Lumexa Imaging’s earnings call?What guidance did Lumexa Imaging's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
